IRIS
AMATI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 642
AS - Asia 559
EU - Europa 362
SA - Sud America 146
AF - Africa 17
OC - Oceania 7
Totale 1.733
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 629
SG - Singapore 297
CN - Cina 192
BR - Brasile 132
FI - Finlandia 86
IT - Italia 84
IE - Irlanda 61
DE - Germania 38
SE - Svezia 27
RU - Federazione Russa 25
GB - Regno Unito 23
IN - India 21
HK - Hong Kong 10
CA - Canada 7
AR - Argentina 6
BD - Bangladesh 6
JP - Giappone 6
TR - Turchia 6
AU - Australia 5
NG - Nigeria 4
NL - Olanda 4
AO - Angola 3
EC - Ecuador 3
KE - Kenya 3
MA - Marocco 3
PE - Perù 3
PH - Filippine 3
GR - Grecia 2
IQ - Iraq 2
JO - Giordania 2
LK - Sri Lanka 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
UA - Ucraina 2
VN - Vietnam 2
ZA - Sudafrica 2
AL - Albania 1
AT - Austria 1
AZ - Azerbaigian 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ES - Italia 1
FR - Francia 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.733
Salva come PNG Salva come JPEG
Città #
Shanghai 154
Singapore 148
The Dalles 130
Boardman 107
Helsinki 86
New York 72
Dublin 61
Ashburn 58
Los Angeles 27
Naples 22
Moscow 19
Milan 17
Pune 16
Chandler 14
London 10
São Paulo 10
Santa Clara 8
Shijiazhuang 8
Seattle 7
Falkenstein 6
Casal di Principe 5
Council Bluffs 5
Hong Kong 5
Rio de Janeiro 5
Wanchai 5
Benin City 4
Hangzhou 4
Phoenix 4
Santo André 4
Southwark 4
Atlanta 3
Cagliari 3
Dolianova 3
Goiânia 3
Guangzhou 3
Guildford 3
Montecassiano 3
Munich 3
Presidente Prudente 3
St Petersburg 3
Amman 2
Ankara 2
Asagayakita 2
Assendelft 2
Athens 2
Auckland 2
Belo Horizonte 2
Berlin 2
Cotia 2
Daiba 2
Dhaka 2
Etobicoke 2
Frankfurt am Main 2
Guarulhos 2
Johnson City 2
Kentville 2
Lawrence 2
Lima 2
Luanda 2
Melbourne 2
Miami 2
Nairobi 2
Pasadena 2
Princeton 2
Queens 2
Ragusa 2
Reston 2
Salvador 2
San Fernando City 2
Sankt Augustin 2
Sarnthein 2
Sydney 2
São José do Rio Preto 2
Turin 2
Verona 2
Viçosa 2
Zhengzhou 2
Americana 1
Amsterdam 1
Aracaju 1
Ashgabat 1
Baghdad 1
Bagé 1
Baku 1
Baoding 1
Bariri 1
Barueri 1
Basra 1
Belgrade 1
Benguela 1
Benton Harbor 1
Betim 1
Birmingham 1
Bishkek 1
Blumenau 1
Bonito 1
Boston 1
Bragado 1
Bragança Paulista 1
Brasília 1
Totale 1.152
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 79
COVID-19 in Immunocompromised Patients: A Systematic Review 71
Community-acquired pneumonia 57
Cardiovascular Complications in Community-Acquired Pneumonia 41
COVID-19 in lung transplant recipients: A case series from Milan, Italy 41
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 41
Treatable traits in interstitial lung diseases: a call to action 40
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 40
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 40
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 39
Cardiovascular side-effects of common antibiotics 38
COVID-19 multidisciplinary high dependency unit: the Milan model 37
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 35
Comparison of different conditions for DNA extraction in sputum - a pilot study 34
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 34
Diagnosis and Initial Investigation of Bronchiectasis 34
Antibiotics for lung disease and cancer 34
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 34
How to Identify Causes and Predisposing Factors in Bronchiectasis 32
Post-COVID-19 sequelae 32
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 31
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 31
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 30
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 30
Respiratory failure in COVID-19: a patient's perspective and clinical cases 29
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 29
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 29
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series 28
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 28
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 28
What is the best technique to extract bacterial DNA from sputum? 28
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 28
Neutrophil elastase in bronchiectasis 23
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 23
Protease-Antiprotease Imbalance in Bronchiectasis 23
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 23
The biology of pulmonary exacerbations in bronchiectasis 23
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia 23
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 22
Site of care and multidisciplinary approach 22
Diagnostic delay in bronchiectasis: an Italian perspective 22
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 21
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 21
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 20
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 20
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 20
Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia 19
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 19
Phenotyping in bronchiectasis: are we moving toward a personalized medicine? 19
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 19
Response to: are there over 200 distinct types of interstitial lung diseases? 18
Walking the path of treatable traits in interstitial lung diseases 17
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients 17
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 17
One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19 17
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity 17
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 17
Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP 16
Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation 16
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 15
Treatable Traits in Systemic Sclerosis 15
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 14
Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis 12
Glucocorticoid Therapy in COVID-19 12
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 10
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis 10
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease 8
Totale 1.812
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 2 3 4 2
2022/2023225 4 3 3 5 6 0 63 8 32 63 27 11
2023/2024715 53 64 122 67 32 107 68 31 9 45 50 67
2024/2025861 15 7 17 24 32 105 55 35 204 209 93 65
Totale 1.812